- Home
- CPS vs LXRX Comparison
CPS vs LXRX Comparison
Compare CPS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- LXRX
- Stock Information
- Founded
- CPS 1960
- LXRX 1995
- Country
- CPS United States
- LXRX United States
- Employees
- CPS N/A
- LXRX N/A
- Industry
- CPS Auto Parts:O.E.M.
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- LXRX Health Care
- Exchange
- CPS Nasdaq
- LXRX Nasdaq
- Market Cap
- CPS 208.1M
- LXRX 228.8M
- IPO Year
- CPS N/A
- LXRX 2000
- Fundamental
- Price
- CPS $23.04
- LXRX $0.63
- Analyst Decision
- CPS Hold
- LXRX Buy
- Analyst Count
- CPS 1
- LXRX 4
- Target Price
- CPS $12.00
- LXRX $3.67
- AVG Volume (30 Days)
- CPS 573.2K
- LXRX 4.1M
- Earning Date
- CPS 05-01-2025
- LXRX 05-13-2025
- Dividend Yield
- CPS N/A
- LXRX N/A
- EPS Growth
- CPS N/A
- LXRX N/A
- EPS
- CPS N/A
- LXRX N/A
- Revenue
- CPS $2,721,537,000.00
- LXRX $31,213,000.00
- Revenue This Year
- CPS N/A
- LXRX N/A
- Revenue Next Year
- CPS $5.00
- LXRX $46.60
- P/E Ratio
- CPS N/A
- LXRX N/A
- Revenue Growth
- CPS N/A
- LXRX 1251.21
- 52 Week Low
- CPS $10.38
- LXRX $0.28
- 52 Week High
- CPS $26.73
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- CPS 60.73
- LXRX 50.34
- Support Level
- CPS $21.45
- LXRX $0.52
- Resistance Level
- CPS $24.38
- LXRX $0.72
- Average True Range (ATR)
- CPS 1.18
- LXRX 0.05
- MACD
- CPS -0.41
- LXRX 0.00
- Stochastic Oscillator
- CPS 31.67
- LXRX 55.52
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.